INTERNATIONAL BIOTECHNOLOGY TST PLC

Net Asset Value • Jul 5, 2023

National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ .g{size:612.0pt 792.0pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.g{}p.u{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal;layout-grid-mode:char;text-autospace:none}span.r{font-size:12.0pt;font-family:"Arial","sans-serif"}span.s{color:black}span.p{font-size:12.0pt;font-family:"Arial","sans-serif";color:black}p.v{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt; text-align:center;line-height:normal;layout-grid-mode:char;text-autospace:none}p.w{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;layout-grid-mode:char;text-autospace:none}p.x{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify}span.m{font-size:12.0pt;line-height:107%;font-family:"Arial","sans-serif"} p.y{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}span.k{font-size:12.0pt; font-family:"Arial","sans-serif"}p.z{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal;}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}span.h{font-family:"Arial","sans-serif"} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .g{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/

RNS Number : 0970F

Intl. Biotechnology Trust PLC

05 July 2023

5 July 2023

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

(the "Company")

Dividend Declaration

At the Annual General Meeting held on 6 December 2022, Shareholders approved the Company's dividend policy of making dividend payments, equivalent to 4 per cent. of the Company's Net Asset Value as at the last day of the preceding financial year (31 August), through two equal semi-annual distributions. In accordance with this policy, the first Interim Dividend for the period ending 31 August 2023 was paid in January 2023.

The Directors have today declared the second Interim Dividend for the period ending 31 August 2023 of 14.2p per Ordinary Share.

The second Interim Dividend will be payable on Friday, 25 August 2023 to holders of Ordinary Shares on the Register at the close of business on Friday, 28 July 2023 (ex-dividend Shares on the Register at Thursday, 27 July 2023).

For further information contact:

Company Secretary - Link Company Matters

Indu Shastri              +44 (0)7936 045789

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNRAMATMTTMBMJ